Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment through advanced 3D modeling techniques.
Thermo Fisher is ready to expand its viral vector production site in Massachusetts once there’s ‘demand for it’
PLAINVILLE, Mass. — Just a year after opening its $180 million viral vector manufacturing site in Massachusetts, Thermo Fisher already has expansion on its mind.